Improving Access to Cervical Cancer Screening
Uterine Cervical Neoplasms
About this trial
This is an interventional screening trial for Uterine Cervical Neoplasms focused on measuring Vaginal HPV self-sampling, Pap test smear, cervical cancer screening, deprivation, sexual and reproductive health, Precariousness
Eligibility Criteria
Inclusion Criteria:
- Women between 25 and 65 years old
- Met within Doctors of the World programs
Exclusion Criteria:
- History of total hysterectomy (= ablation of uterus and cervix)
- Never had sexual intercourse
- Last pap smear test made during the three last years (ou first pap smear test during the last year)
Sites / Locations
- Médecins du Monde
Arms of the Study
Arm 1
Arm 2
Experimental
Experimental
Pap smear
Self-collected vaginal swab for HPV testing + pap smear triage
'Pap smear' arm: women are invited to participate in a preventive consultation. This consultation is followed by direct patient referral for Pap smear testing in a partner health facility.
'Self-collected vaginal swab for HPV testing + pap smear triage' arm : women are invited to participate in a preventive consultation. This consultation is followed by patient referral for Pap smear testing in a partner health facility if the HPV-HR test is positive. A women who tests negative for HPV-HR can still be referred for further Pap smear testing, or can be referred for a gynaecological consultation for any other reason.